SENSEX NIFTY

Ranbaxy Laboratories

Jul 23, 2014 at 10:42 | Source: Moneycontrol.com
With DPCO coverage extending to almost about 40 percent of the industry, the profitability in the domestic business of pharma companies is likely to come under pressure, says an ICRA report.
Jul 22, 2014 at 10:37 | Source: Moneycontrol.com
According to Satish Gupta of astrostocktips.in, leather stocks like Bata India, Liberty Shoes, Superhouse and Relaxo Footwears and pharma stocks like Biocon, Brooks Laboratories, Dishman Pharma, Dr Reddys Laboratories and Ranbaxy Laboratories will get astro support.
Jul 21, 2014 at 11:07 | Source: CNBC-TV18
VK Sharma of HDFC Securities recommends a bull spread strategy in Ranbaxy Laboratories wherein on may buy 560 Call and sell 580 Call.
Jul 21, 2014 at 08:24 | Source: CNBC-TV18
Reliance Industries | HDFC | HDFC Bank | Sun Pharma | Ranbaxy Labs | Wockhardt | Coal India | Hindalco Industries | Kotak Mahindra Bank | MCX India | Financial Technologies | UltraTech Cement | SKF India | Clariant Chemicals | Motilal Oswal | Oberoi Realty and Ramco Systems are stocks, which are in the news today.
Jul 18, 2014 at 08:16 | Source: CNBC-TV18
TCS | Mindtree | Bajaj Holdings | Rallis India | Gammon Infrastructure | Jet Airways | State Bank of India | Repco Home Finance | Pantaloons Fashion Retail | Sun Pharma | Ranbaxy Labs | Indian Hotels | Cipla | Mahindra and Mahindra | Muthoot Finance | SKS Microfinance | Tata Power and Zee Entertainment are stocks, which are in the news today.
Jul 17, 2014 at 09:43 | Source: CNBC-TV18
Sudarshan Sukhani of s2analytics.com recommends buying Lupin.
Jul 16, 2014 at 19:07 | Source: Moneycontrol.com
According to Lahiri, pharma and e-commerce have been the big winners in the first half with mega deals like Sun Pharma acquiring Ranbaxy and Flipkart buying out Myntra.
Jul 16, 2014 at 18:25 | Source: CNBC-TV18
CNBC-TV18's Shereen Bhan spoke to Kiran Mazumdar Shaw, CMD of Biocon and CM Gulati is Editor, Monthly Index of Medical Specialities (MIMS) to get their perspective on how the governments new move is likely to impact the pharma industry.
Jul 16, 2014 at 10:09 | Source: CNBC-TV18
NPPA has cut and capped prices of some major anti-diabetes and cardiovascular drugs that were not part of the 652 drugs earlier listed out by the government as essential drugs last year.
Jul 16, 2014 at 10:07 | Source: Moneycontrol.com
Sun Pharmaceutical Industries announced that its subsidiary acquired US-based Pharmalucence Inc.
Messages on Ranbaxy Laboratories »

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 15:14 hrs, the share was quoting at Rs 545.65, up Rs 2.50, or 0.46%. See more

3.15 PM Jul 8th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

At 15:14 hrs, Ranbaxy Laboratories was trading at Rs 545.65 up 0.46%, with a huge increase in its volume of shares traded. Till now over 220,541 shares were traded as compared to its 5-day average of 106,981 shares.

3.15 PM Jul 8th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 14:14 hrs, the share was quoting at Rs 550.20, up Rs 7.05, or 1.30%. See more

2.15 PM Jul 8th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 13:14 hrs, the share was quoting at Rs 552.10, up Rs 8.95, or 1.65%. See more

1.15 PM Jul 8th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 12:14 hrs, the share was quoting at Rs 550.65, up Rs 7.50, or 1.38%. See more

12.15 PM Jul 8th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 557.00. At 11:14 hrs, the share was quoting at Rs 552.35, up Rs 9.20, or 1.69%. See more

11.15 AM Jul 8th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 15:14 hrs, the share was quoting at Rs 533.20, down Rs 0.10, or 0.02%. See more

3.15 PM Jul 4th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 14:14 hrs, the share was quoting at Rs 532.20, down Rs 1.10, or 0.21%. See more

2.15 PM Jul 4th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 13:13 hrs, the share was quoting at Rs 531.20, down Rs 2.10, or 0.39%. See more

1.15 PM Jul 4th

Market Statistician

Platinum Member

9292 Followers

Ranbaxy Labs  

Ranbaxy Laboratories has touched a 52-week high of Rs 538.45. At 12:14 hrs, the share was quoting at Rs 532.15, down Rs 1.15, or 0.22%. See more

12.15 PM Jul 4th

News across the web »
Jul 17, 2014 at 03:47 | Source: Calcutta Telegraph News
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.